Currently, out of the existing stock ratings of Donald Ellis - 38 which are a Buy (95%), 2 which are a Hold (5%)

Donald Ellis

Work Performance Price Targets & Ratings Chart

Analyst Donald Ellis works at JMP and is covering the Healthcare sector with 73 price targets and ratings displayed on 8 stocks.

Donald Ellis's average stock forecast success ratio is 45.42% with an average time for price targets to be met of 338.25 days.

Most recent stock forecast was given on CLSD, Clearside Biomedical at 21-Dec-2021.

Wall Street Analyst Donald Ellis

Analyst best performing recommendations are on OCUL (OCULAR THERAPEUTIX).
The best stock recommendation documented was for CLSD (CLEARSIDE BIOMEDICAL) at 8/22/2019. The price target of $3 was fulfilled within 124 days with a profit of $2.22 (284.62%) receiving and performance score of 22.95.

Average potential price target upside

of $17.37 (45.08%) on PCRX (PACIRA BIOSCIENCES).
of $13.22 (34.04%) on AERI (AERIE PHARMACEUTICALS).
of $8.93 (43.95%) on HZNP (HORIZON THERAPEUTICS PUBLICCOMPANY).

ACRS Aclaris Therapeutics AERI Aerie Pharmaceuticals ENDP Endo International plc HZNP Horizon Therapeutics PublicCompany CLSD Clearside Biomedical OCUL Ocular Therapeutix PCRX Pacira BioSciences SLGL SolGel Technologies Ltd

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Louise Chen (CANTOR FITZGERALD)